Actualités FluoroPharma Medical Inc (CE) - FPMI | Actions OTCMarkets

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM...

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources: filename1.pdf

Proxy Statement (definitive) (def 14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SC...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM...

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SC...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Quarterly Report (10-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM...

Small Company Offering and Sale of Securities Without Registration (d)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM...

Annual Report (10-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed Pursuant to Rule 424(b)(3) Registration No. 333-208196 PROSPECTUS FLUOROPHAR...

Securities Registration Statement (s-1/a)

As filed with the Securities and Exchange Commission on February 4 , 2016 Registration No. 333-208196 UNITED...

Securities Registration Statement (s-1/a)

As filed with the Securities and Exchange Commission on January 26, 2016 Registration No. 333-208196 UNITED...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

FluoroPharma Medical Inc (CE) (FPMI)

Outils de qualité professionnelle, pour des investisseurs individuels.

FPMI Actualités

Current Report Filing (8-k)

Confidential Treatment Order (ct Order)

Proxy Statement (definitive) (def 14a)

Current Report Filing (8-k)

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

Current Report Filing (8-k)

Current Report Filing (8-k)

Quarterly Report (10-q)

Current Report Filing (8-k)

Small Company Offering and Sale of Securities Without Registration (d)

Annual Report (10-k)

Current Report Filing (8-k)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Securities Registration Statement (s-1/a)

Securities Registration Statement (s-1/a)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

FluoroPharma Medical Inc (CE) (FPMI) Actualités

FluoroPharma Medical Inc (CE) (FPMI)

Outils de qualité professionnelle, pour des investisseurs individuels.

FPMI Actualités

Current Report Filing (8-k)

Confidential Treatment Order (ct Order)

Proxy Statement (definitive) (def 14a)

Current Report Filing (8-k)

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

Current Report Filing (8-k)

Current Report Filing (8-k)

Quarterly Report (10-q)

Current Report Filing (8-k)

Small Company Offering and Sale of Securities Without Registration (d)

Annual Report (10-k)

Current Report Filing (8-k)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Securities Registration Statement (s-1/a)

Securities Registration Statement (s-1/a)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application